DEF: Corvus Pharmaceuticals Announces Annual Meeting of Stockholders to be Held Virtually on June 12, 2025

Corvus Pharmaceuticals will hold its annual meeting of stockholders virtually on June 12, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.

Summary

• Corvus Pharmaceuticals, Inc. will hold its annual meeting of stockholders on June 12, 2025, at 1:00 p.m. Pacific Time.
• The meeting will be held entirely online at www.meetnow.global/MPVXYD4.
• Stockholders of record as of April 17, 2025, are entitled to vote.
• The agenda includes the election of two Class III Directors, ratification of PricewaterhouseCoopers LLP as the independent accounting firm for the fiscal year ending December 31, 2025, and a non-binding advisory vote on executive compensation.
• The board recommends voting FOR the election of director nominees, FOR the ratification of the accounting firm, and FOR the approval of executive compensation.
• Stockholders can vote online, by phone, or by mail.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and informative tone. The board's recommendations suggest a positive outlook on the company's direction.

Positives

• The virtual format of the annual meeting allows for greater participation and improved communication.
• Electronic delivery of proxy materials reduces printing and mailing costs and environmental impact.

Future Outlook

The document outlines the procedures and proposals for the upcoming annual meeting, indicating a focus on corporate governance and shareholder engagement.

Management Comments

• On behalf of the board of directors, thank you for your participation in this important annual process, said Richard A. Miller, M.D., President and Chief Executive Officer.

Industry Context

The use of a virtual annual meeting format reflects a growing trend in corporate governance to enhance accessibility and reduce costs.

Comparison to Industry Standards

• The director compensation program is similar to those of other small-cap biopharmaceutical companies.
• The company's corporate governance guidelines align with best practices for publicly traded companies.

Management Changes

Stakeholder Impact

• Shareholders are asked to vote on key decisions affecting the company's governance and direction.
• The outcome of the votes will influence the composition of the board and executive compensation.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the annual meeting on June 12, 2025.
• The company will announce the voting results in a Form 8-K filed with the SEC.

Key Dates

Keywords

annual meeting, proxy statement, stockholders, corporate governance, director election, executive compensation, PricewaterhouseCoopers, virtual meeting, voting